| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FLS | Common Stock | Options Exercise | $0 | +71,995 | +21% | $0.000000 | 421,717 | 13 Feb 2025 | Direct | F1 |
| transaction | FLS | Common Stock | Tax liability | $1,756,336 | -28,328 | -6.7% | $62.00 | 393,389 | 13 Feb 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FLS | Performance Rights | Award | $0 | +61,669 | +24% | $0.000000 | 322,576 | 13 Feb 2025 | Common Stock | 61,669 | Direct | F2 | |
| transaction | FLS | Restricted Stock Units | Award | $0 | +50,456 | +122% | $0.000000 | 91,843 | 13 Feb 2025 | Common Stock | 50,456 | Direct | F3 | |
| transaction | FLS | Performance Rights | Options Exercise | $0 | -67,414 | -21% | $0.000000 | 255,162 | 13 Feb 2025 | Common Stock | 67,414 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | Includes 210 shares of the issuer's common stock acquired under the Flowserve Employee Stock Purchase Plan in monthly transactions that were exempt under Rule 16b-3. |
| F2 | Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period. |
| F3 | Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025. |
| F4 | Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 76.7% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024, which are: 1) the issuer's free cash flow ("FCF") as a percent of adjusted net income for the performance period in comparison to the issuer's targeted free cash flow as a percent of adjusted net income for the performance period; and 2) the issuer's return on invested capital ("ROIC") for each calendar year in the performance period measured against the issuer's targeted ROIC for each calendar year under its operating plan. The performance rights were also subject to a 15% payout modifier (positive or negative) based on the issuer's total shareholder return ("TSR") in comparison to the TSR of peer companies for the entire performance period. |